| Mark S Rubin, RPH | |
|
908 Scarbro Road, New River Health Center Pharmacy, Scarbro, WV 25917 | |
| (304) 469-3424 | |
| (304) 929-6776 |
| Full Name | Mark S Rubin |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 908 Scarbro Road, Scarbro, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518932623 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP0004046 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark S Rubin, RPH 163 Rubin Dr, Beckley, WV 25801-2155 Ph: (304) 573-8819 | Mark S Rubin, RPH 908 Scarbro Road, New River Health Center Pharmacy, Scarbro, WV 25917 Ph: (304) 469-3424 |
News Archive
The University of Pittsburgh's McGowan Institute for Regenerative Medicine, which connects scientists who work on tissue engineering, cell therapies, artificial organs and biodevices, has been awarded a Shared University Research (SUR) Award from IBM ( IBM). The IBM SUR Award will provide IBM computer hardware, software and services to Pitt for its cutting-edge "in silico" biological research, which uses computer simulations to explore biological pathways and test therapeutic interventions.
According to a new report from State Coverage Initiatives, federal policymakers crafting health reform have yet to address the critical issue of how new or modified federal rules will impact health care delivery systems, insurance regulation, and safety net programs administered by the states.
Intelsius, a global manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announces a strategic partnership with American Thermal Instruments (ATI), a leader in temperature monitoring, inspections and asset tracking.
e-Therapeutics plc (AIM:ETX) announced today that it has dosed the first healthy volunteer in a newly initiated Phase I clinical trial with an oral formulation of its anti-cancer compound, ETS2101.
The Scripps Research Institute and the University of California, San Diego, School of Medicine have been awarded approximately $7.5 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of nicotine dependence, and possibly other drug addictions.
› Verified 4 days ago
Jamie Katherine Schraer, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 908 Scarbro Road, Scarbro, WV 25917 Phone: 304-469-3424 Fax: 304-465-2266 | |
Jeanette D. Shrewsbury, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 908 Scarbro Road, Scarbro, WV 25917 Phone: 304-469-3424 Fax: 304-929-6776 | |
Lindsay J. Avancini, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 908 Scarbro Rd, Scarbro, WV 25917 Phone: 304-469-3424 Fax: 304-929-6776 |